A non-ventilator ET tube cap used to oxygenate a patient during an intubation procedure. The ET tube cap generally comprises an oxygen source connector configured to connect to an oxygen source via an oxygen tube. This provides oxygen to a patient via an ET tube while being intubated. The ET tube cap further includes an ET tube receiving aperture that is specifically arranged to engage an ET tube in a removable relationship prior to the ET tube connected to a ventilator while the ET tube is deployed in a patient. Optionally, the ET tube cap can comprise at least two pressure relief valves that open when pressure inside of the ET tube cap exceeds a predetermined pressure threshold to prevent harm to the patient that is being intubated.

A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.

A ventilator including a housing; a gas inlet port disposed in the housing and adapted to be coupled to a gas source to receive a flow of gas; a valve assembly coupled with the gas inlet port for controlling flow of gas from the gas inlet port to a gas outlet port disposed in the housing and adapted for being coupled to a patient interface to fluidly couple the gas outlet port to the airway of a patient; a controller module disposed in the housing, the controller module comprising a controller operatively coupled with the valve assembly to control operation of the valve assembly; an airway pressure sensor positioned between the valve assembly and the patient interface to measure air flow output into flowing into the airway of the patient; wherein the pressure sensor is operatively connected to the controller module to control the operation of the valve assembly in response to changes in air flow output measured by the airway pressure sensor during use.

A patient interface is disclosed that includes: a plenum chamber pressurisable to a therapeutic pressure; a seal-forming structure joined to the plenum chamber and comprising a nasal portion, an oral portion, and at least one hole configured to deliver a flow of air at said therapeutic pressure to at least the patients nares in use, the seal-forming structure constructed and arranged to maintain said therapeutic pressure in the plenum chamber throughout the patients respiratory cycle in use; a vent comprising a plurality of holes configured to allow a continuous vent flow from an interior of the plenum chamber to ambient; a positioning and stabilising structure comprising at least one tie and being configured to hold the seal-forming structure in a therapeutically effective position on the patient's head in use; and a textile portion configured to contact the patients face.

Methods and apparatus provide automated circuit disconnection monitoring such as for a respiratory apparatus or system. Disconnection of a patient circuit, including a patient interface and air delivery circuit, may be detected and a message or alarm activated. In some versions, detecting occurrences of circuit disconnection event(s), such as by a processor, may be based on an instantaneous disconnection parameter as a function of a disconnection setting. The disconnection setting may be determined based on patient circuit type. The instantaneous disconnection parameter may be determined from detected pressure and flow rate, and may be, for example, a conductance value or an impedance value. Disconnection events may be qualified by one or more detected respiratory indicators. In some cases, instantaneous impedance or conductance may be used to assess re-connection of a patient circuit, detection of flow starvation, determine breath shape for triggering and cycling and to detect patient or circuit obstructions.

A high flow therapy system for delivering heated and humidified respiratory gas to an airway of a patient includes a respiratory gas flow pathway for delivering the respiratory gas to the airway of the patient by way of a non-sealing respiratory interface; wherein flow rate of the respiratory gas is controlled by a microprocessor, a mixing area for mixing a first gas and a second gas in the respiratory gas flow pathway, a humidification area downstream of the mixing area and configured for humidifying respiratory gas in the respiratory gas flow pathway, and a heated delivery conduit for minimizing condensation of humidified respiratory gas.

A high flow therapy system for delivering heated and humidified respiratory gas to an airway of a patient includes a respiratory gas flow pathway for delivering the respiratory gas to the airway of the patient by way of a non-sealing respiratory interface; wherein flow rate of the respiratory gas is controlled by a microprocessor, a mixing area for mixing a first gas and a second gas in the respiratory gas flow pathway, a humidification area downstream of the mixing area and configured for humidifying respiratory gas in the respiratory gas flow pathway, and a heated delivery conduit for minimizing condensation of humidified respiratory gas.

Embodiments of the present disclosure include a nasal pillow apparatus having a first nasal pillow, a second nasal pillow, and a connecting bar that connects the first nasal pillow to the second nasal pillow, the connecting bar being disposed below a bottom surface of the first nasal pillow and a bottom surface of the second nasal pillow. Each of the first nasal pillow and the second nasal pillow includes an inner wall having a first end and a second end opposite the first end; and an outer wall connected to the second end of the inner wall. When inserted into a nostril of a patient, the outer wall is configured to conform to the nostril by compressing in a first direction and expanding in a second direction.

The invention relates to the field of medicine, and more particularly to emergency medical assistance. A respiratory intervention is performed on a patient with an artificial gas-air mixture having an increased content of argon of at least 30 vol %, enabling this artificial gas-air mixture to be effective continuously throughout the procedure. Furthermore, the respiratory gaseous medium has an increased content of oxygen with xenon being added and has the following composition: 1-10 vol % of xenon; 30-35 vol % of argon; 60-65 vol % of oxygen. The intervention on the patient with the artificial gas-air mixture of the composition mentioned is performed for 20-40 minutes or more, until specialized medical assistance is given. The method makes it possible to increase the effectiveness, safety and rapidity of relieving acute cerebral and cardiac ischemia, and to reduce the risk of developing an acute cerebral stroke or myocardial infarction.

The invention relates to the field of medicine, and more particularly to emergency medical assistance. A respiratory intervention is performed on a patient with an artificial gas-air mixture having an increased content of argon of at least 30 vol %, enabling this artificial gas-air mixture to be effective continuously throughout the procedure. Furthermore, the respiratory gaseous medium has an increased content of oxygen with xenon being added and has the following composition: 1-10 vol % of xenon; 30-35 vol % of argon; 60-65 vol % of oxygen. The intervention on the patient with the artificial gas-air mixture of the composition mentioned is performed for 20-40 minutes or more, until specialized medical assistance is given. The method makes it possible to increase the effectiveness, safety and rapidity of relieving acute cerebral and cardiac ischemia, and to reduce the risk of developing an acute cerebral stroke or myocardial infarction.